TAICEND is set to officially launch its groundbreaking new product — TAICEND Collagen Dressing — in 2026. Extracted from premium fish skin, the collagen is produced through a patented low-temperature extraction technology combined with a proprietary formulation, resulting in a high-purity fish collagen suitable for advanced wound dressings.

Compared to traditional fish skin dressings, which are difficult to source, preserve, and apply, TAICEND's fish collagen powder features a sterile bottled design that ensures safety, hygiene, and ease of use. The powder form allows for better absorption and provides critical support for effective wound healing.

The formulation preserves the triple-helix structure of fish collagen, creating a stable biological scaffold that enhances cellular support throughout the healing process. With a smaller molecular weight than bovine or porcine collagen, fish collagen offers excellent biocompatibility and higher patient acceptance. Enriched with compound amino acids, the formula helps regulate inflammatory responses, activate fibroblasts, and provide essential cellular nutrients to accelerate granulation tissue formation while maintaining an optimal moist healing environment.

For challenging wounds such as pressure ulcers and diabetic foot ulcers, TAICEND's fish collagen dressing significantly reduces recovery time and promotes faster tissue repair—offering clinicians a new therapeutic option that transforms wound care from "stalled healing" to "accelerated recovery."